SLEEPING GIANT CAPITAL CORP (SSX.CA) Fundamental Analysis & Valuation

TSX-V:SSX • CA83126J1030

Current stock price

0.05 CAD
0 (0%)
Last:

This SSX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SSX.CA Profitability Analysis

1.1 Basic Checks

  • SSX had negative earnings in the past year.
  • In the past year SSX has reported a negative cash flow from operations.
  • In the past 5 years SSX always reported negative net income.
  • In the past 5 years SSX always reported negative operating cash flow.
SSX.CA Yearly Net Income VS EBIT VS OCF VS FCFSSX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -100K -200K -300K -400K

1.2 Ratios

Industry RankSector Rank
ROA -53.11%
ROE -122.1%
ROIC N/A
ROA(3y)-26.35%
ROA(5y)N/A
ROE(3y)-37.65%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SSX.CA Yearly ROA, ROE, ROICSSX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

  • SSX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SSX.CA Yearly Profit, Operating, Gross MarginsSSX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -50 -100 -150 -200 -250

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. SSX.CA Health Analysis

2.1 Basic Checks

  • SSX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SSX has more shares outstanding than it did 1 year ago.
  • There is no outstanding debt for SSX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SSX.CA Yearly Shares OutstandingSSX.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
SSX.CA Yearly Total Debt VS Total AssetsSSX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200K 400K 600K 800K 1M

2.2 Solvency

  • Based on the Altman-Z score of -2.10, we must say that SSX is in the distress zone and has some risk of bankruptcy.
  • There is no outstanding debt for SSX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.1
ROIC/WACCN/A
WACC9.09%
SSX.CA Yearly LT Debt VS Equity VS FCFSSX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200K -200K 400K -400K 600K

2.3 Liquidity

  • A Current Ratio of 0.71 indicates that SSX may have some problems paying its short term obligations.
  • SSX has a Quick Ratio of 0.71. This is a bad value and indicates that SSX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.71
SSX.CA Yearly Current Assets VS Current LiabilitesSSX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 100K 200K 300K 400K

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. SSX.CA Growth Analysis

3.1 Past

  • The earnings per share for SSX have decreased strongly by -139.33% in the last year.
  • Looking at the last year, SSX shows a very strong growth in Revenue. The Revenue has grown by 187.56%.
EPS 1Y (TTM)-139.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80%
Revenue 1Y (TTM)187.56%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.53%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSX.CA Yearly Revenue VS EstimatesSSX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 50K 100K 150K

More info and screens

Find the best growth stocksShow best growing peers

0

4. SSX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SSX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SSX.CA Price Earnings VS Forward Price EarningsSSX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SSX.CA Per share dataSSX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SSX.CA Dividend Analysis

5.1 Amount

  • No dividends for SSX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SSX.CA Fundamentals: All Metrics, Ratios and Statistics

SLEEPING GIANT CAPITAL CORP

TSX-V:SSX (4/6/2026, 7:00:00 PM)

0.05

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)12-01
Earnings (Next)04-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners10.2%
Ins Owner ChangeN/A
Market Cap640.00K
Revenue(TTM)286.70K
Net Income(TTM)-545.30K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.23
P/FCF N/A
P/OCF N/A
P/B 1.43
P/tB 1.43
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.02
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -53.11%
ROE -122.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.94%
FCFM N/A
ROA(3y)-26.35%
ROA(5y)N/A
ROE(3y)-37.65%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.6%
Cap/Sales 7.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.71
Altman-Z -2.1
F-Score3
WACC9.09%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-139.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)187.56%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-189.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-409.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-308.67%
OCF growth 3YN/A
OCF growth 5YN/A

SLEEPING GIANT CAPITAL CORP / SSX.CA Fundamental Analysis FAQ

What is the fundamental rating for SSX stock?

ChartMill assigns a fundamental rating of 1 / 10 to SSX.CA.


Can you provide the valuation status for SLEEPING GIANT CAPITAL CORP?

ChartMill assigns a valuation rating of 0 / 10 to SLEEPING GIANT CAPITAL CORP (SSX.CA). This can be considered as Overvalued.


What is the profitability of SSX stock?

SLEEPING GIANT CAPITAL CORP (SSX.CA) has a profitability rating of 0 / 10.